menu-hamburger-svgrepo-com

Betadine products prove 99.99% effective against COVID-19

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Mundipharma, the distributor of Betadine products, announced these results after the TIDREC research9 was accepted by the British Dental Journal (BDJ) and published as a Letter on 26 June 2020, and the Duke-NUS research was published in the respected Infectious Disease and Therapy Journal on 08 July 20201.

Betadine products contain povidone-iodine (PVP-I), which has been widely used throughout the world as an antiseptic since the middle of last century. Shannon te Roller, General Manager of Mundipharma South Africa, says, “Betadine products with PVP-I have been well accepted in South Africa for home use and by the medical community for decades, with benefits that include no reported antimicrobial resistance, fast-acting, a long-lasting effect, and extremely low allergenicity on skin 3.”

The TIDREC research concludes that the broad-spectrum antimicrobial and rapid virucidal activity of PVP-I products against SARS-CoV-2 suggests its importance in infection control. It goes on to note that, as an additional protective barrier to PPE, these products may reduce disease transmission. PVP-I is easily administered and has been used in both hospital and community settings for more than 55 years* and can thus be readily integrated into existing infection control protocols. PVP-I based products can be used as part of infection control measures during the COVID-19 pandemic and can augment health and hygiene measures to reduce the spread of COVID-191.

Up-to-the-minute scientific research7,8,9 backs up the use and efficacy of Betadine against the novel coronavirus, and across the world in a variety of medical disciplines including orthopaedic surgery10, dentistry and dental surgery, and ENT surgery 11, 12 13. The use of PVP-I has been recommended in protocols in response to the COVID-19 pandemic. In SA, the South African Dental Association (SADA), recommends its use during patient treatment and pre-operatively, stating that, to this end, the most important method for reducing the viable bacterial and viral load is through pre-procedural rinsing with PVP-I (0.23% to 1%) or 1% hydrogen peroxide rinse2.

Betadine Mouthwash and Gargle is recommended for use for infections of mouth and throat at full strength, or as a mouthwash, diluted one part with two parts of water; Betadine Surgical Scrub is used for disinfecting hands in the medical and dental profession; and Betadine Antiseptic Ointment is used to effectively stop bacteria, fungi, and viruses from infecting injuries caused by minor daily accidents.

Past studies have also shown that PVP-I has the broadest antimicrobial activity of available antiseptics and has been used to combat the spread of infection against a wide range of viruses, including highly pathogenic and low pathogenic influenza viruses (H1N1, H3N2, H1N2, H5N3, H7N7, and HpN2), and SARS and MERS coronaviruses. In all instances, rapid virucidal activity has been demonstrated with both Betadine Mouthwash and Gargle and Betadine® Surgical Scrub3,4,5,6.

For more information, please visit www.mundipharma.co.za/

 

REFERENCES

1 Anderson DE, Sivalingam V, Kang AEZ, et al. Povidone-Iodine Demonstrates Rapid In Vitro Virucidal Activity Against SARS-CoV-2, The Virus Causing COVID-19 Disease. Infect Dis Ther. 2020. https://doi.org/10.1007/s40121-020-00316-3.

2 The South African Dental Association. SADA Dental Protocol in Response to the Covid-19 Pandemic. 2020.

3 Lachapelle J-M, Castel O, Fueyo Casado A, et al. Antiseptics in the era of bacterial resistance with - focus on povidone iodine. Clin Pract 2013;10(5):579-59.

4 Eggers M, Eickamnn M, Zorn J. Rapid and Effective Virucidal Activity of Povidone-Iodine Products Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and Modified Vaccinia Virus Ankara (MVA). Infect Dis Ther 2015;4:491 -501.

5 Eggers M, Eickman M, Zorn J. Can oral disinfection with povidone iodine prevent viral respiratory infections? Poster ASN226 IMRP Singapore 2015.

6 Kanagalingam J, Feliciano R, Hah JH, et al. Practical use of povidone-iodine antiseptic in the maintenance of oral health and in the prevention and treatment of common oropharyngeal infections. Int J Clin Pract 2015;69(11):1247-1256.

7 Mady LJ, Kubik MW, Baddour K, et al. Oral Oncology (2020); in Press https://doi.org/10.1016/j.oraloncology.2020.104724.

8 Ather A, Patel B, Ruparelet NB et al. Journal of Endodontics 46(5): in press https:// www.aae.org/specialty/clinical-resources/coronavirus-disease-19-covid-19-implications-for-clinical-dental-care/.

9 P. Hassandarvis, V. Tiong, A. B. Sazaly, Malaya, Malaysia; N. A. Mohamed, Kuala Lumpur, Malaysia; H. Arumugam, A. Ananthanarayanan, M. Qasuri, Y. Hadjiat, Singapore (2020); in Press https://doi.org/10.1038/s41415-020-1794-1

10 Emanuel C et al. Prevention of Infection and Disruption of the Pathogen Transfer Chain in Elective Surgery. The Journal of Arthroplasty 2020: 35: S28-S31.https://www.ncbi.nlm.nih.gov/research/coronavirus/publication/32389410

11. Bidra AS et al. Rapid In-Vitro Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Using Povidone-Iodine Oral Antiseptic Rinse. Journal of Prosthodontics 2020. https://www.ncbi.nlm.nih.gov/research/coronavirus/publication/32511851

12 Challacombe SJ et al. Povidone Iodine.  2020;228(9):656‐657. doi:10.1038/s41415-020-1589-4 https://pubmed.ncbi.nlm.nih.gov/32385428

 

 

 

13 Kham M et al. Repurposing 0.5% povidone iodine solution in otorhinolaryngology practice in  Covid 19 pandemic.  American Journal of Otolaryngology. 2020: 41: 5: 102618. https://www.ncbi.nlm.nih.gov/research/coronavirus/publication/32574894

Suggested Articles

Suggested Clinical & CPD content

CPD: 1pt
CPD: 1pt

Related articles

Welcome to Medical Academic​

Get the most out of Medical Academic by telling us your occupation. This helps us create more great content for you and the community.

idea

1000’s of Clinical and CPD content compiled by Key Opinion Leaders and our expert medical editors.

connection

Access to medical webinars and events

Group 193

Access medical journals from industry leaders and expert medical editorials.

Congratulations! Your account was successfully created.

Please check your email for an activation mail. Click the activation link to activate your account

Stay up to date

Search for anything across CPD, webinars and journals
idea

1000’s of Clinical and CPD content compiled by Key Opinion Leaders and our expert medical editors.

connection

Access to medical webinars and events

Group 193

Access medical journals from industry leaders and expert medical editorials.

Congratulations! You have successfully booked your seat.

All webinar details will be emailed to your email address.

Did you know, you can book future webinars with a single click if you register an account with Medical Academic.

Congratulations! Your account was successfully created.

Your webinar seat has been booked and all webinar details will be emailed to your registered email address

Why not register for Medical Academic while booking your seat for this webinar?

Future Medical Academic webinars can be booked with a single click, all with a Medical Academic account… and it’s FREE.

Book webinar & create your account

* (Required)

idea

1000’s of Clinical and CPD content compiled by Key Opinion Leaders and our expert medical editors.

connection

Access to medical webinars and events

Group 193

Access medical journals from industry leaders and expert medical editorials.

Congratulations! Your account was successfully created.

Thank you for registering. You can now log in to your account.

Create your account

* (Required)

Login with One Time Pin (OTP)

Enter your registered email address to receive an OTP

A verification code will be sent to your email address. Please ensure that admin@medicalacademic.co.za is on your safe sender list.

We've sent your OTP